Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive
1590.7000 41.50 (2.68%)
NSE Jul 29, 2026 15:31 PM
Volume: 1.0M
 

logo
Aurobindo Pharma Ltd.
07 Nov 2025
1590.70
2.68%
buy
by Axis Direct
Target: 1345 | Target met
Axis Direct
We maintain our BUY recommendation on the stock with a TP of Rs 1,345/share.
 
Number of FII/FPI investors increased from 749 to 781 in Jun 2026 qtr.
More from Aurobindo Pharma Ltd.
Recommended
Market closes higher, led by gains in metal and IT stocks
Trendlyne Marketwatch | 29 Jul 2026, 03:57PM
Five stocks to buy from analysts this week - July 28, 2026
The Baseline | 28 Jul 2026, 05:08PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020